Graeme Downie MP: written questions
Graeme Downie MP: full overview
4 Jul 2024–3 Jul 2025
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Written questions: dates and coverage
- Source checked
- 21 Nov 2026
- Last successful import
- 21 Nov 2026
- Records dated through
- 20 Nov 2026
- Selected period
- Reporting year 1: 4 Jul 2024 to 3 Jul 2025
- Completeness
- Published snapshot: 25,747 records in the source window 23 Aug 2026 to 21 Nov 2026. The published snapshot covers its stated source window. Answers and corrections can appear later; no indexed answer does not prove that none exists.
Understand written questions, dates and answers.
Read what this MP said, asked and contributed in Parliament.
23 published records · newest first.
Written questions
Medical Equipment: Disease ControlDepartment of Health and Social CareTabled 30 Jun 2025AnsweredUIN 63802More
Question: To ask the Secretary of State for Health and Social Care, what methods the NHS uses to sterilise equipment to help prevent vCJD contamination; how long these methods have been used for; and what assessment he has made on the effectiveness of these methods
Answer: The National Health Service in England employs a stratified approach, combining extended autoclaving, enhanced washing, prion specific chemicals, and the destruction of high-risk instruments. The Health Technical Memorandum 01-01: Management and decontami...
Answered 8 Jul 2025
Original Parliament recordRitlecitinib: AlopeciaDepartment of Health and Social CareTabled 19 May 2025AnsweredUIN 53391More
Question: To ask the Secretary of State for Health and Social Care, whether he plans to update guidance on the use of Ritlecitinib to treat alopecia.
Answer: The National Institute for Health and Care Excellence (NICE) is the independent body that makes recommendations for the National Health Service in England on the use of new medicines, based on an assessment of clinical and cost effectiveness. The NHS in E...
Answered 23 May 2025
Original Parliament recordRitlecitinib: AlopeciaDepartment of Health and Social CareTabled 19 May 2025AnsweredUIN 53390More
Question: To ask the Secretary of State for Health and Social Care, what guidance his Department provides to health boards on whether they should consider (a) the mental health impacts of alopecia and (b) other factors prior to prescribing Ritlecitinib.
Answer: The National Institute for Health and Care Excellence (NICE) is the independent body that makes recommendations for the National Health Service in England on the use of new medicines, based on an assessment of clinical and cost effectiveness. The NHS in E...
Answered 2 Jun 2025
Original Parliament recordRitlecitinib: AlopeciaDepartment of Health and Social CareTabled 19 May 2025AnsweredUIN 53389More
Question: To ask the Secretary of State for Health and Social Care, how many health boards have used Ritlecitinib to treat alopecia in the last 12 months.
Answer: The NHS Business Services Authority and NHS England only hold prescribing data for ritlecitinib in England. As health is a devolved issue, information relating to the use of ritlecitinib by Scottish health boards would be held by the Scottish health autho...
Answered 22 May 2025
Original Parliament recordAlopecia: Medical TreatmentsDepartment of Health and Social CareTabled 19 May 2025AnsweredUIN 53388More
Question: To ask the Secretary of State for Health and Social Care, what factors health boards are advised to use in addition to Severity of Alopecia Tool scores when determining the correct treatment for alopecia.
Answer: Healthcare is a devolved matter, and our response outlines information for England only. The Scottish Government is responsible for the activities and decisions of health boards in Scotland.We have made no assessment of the effectiveness of the Severity o...
Answered 2 Jun 2025
Original Parliament recordAlopecia: Medical TreatmentsDepartment of Health and Social CareTabled 19 May 2025AnsweredUIN 53387More
Question: To ask the Secretary of State for Health and Social Care, whether Severity of Alopecia Tool scores are the only factor that health boards are advised to use when determining the correct treatment for alopecia.
Answer: Healthcare is a devolved matter, and our response outlines information for England only. The Scottish Government is responsible for the activities and decisions of health boards in Scotland.We have made no assessment of the effectiveness of the Severity o...
Answered 2 Jun 2025
Original Parliament recordAlopecia: Medical TreatmentsDepartment of Health and Social CareTabled 19 May 2025AnsweredUIN 53386More
Question: To ask the Secretary of State for Health and Social Care, what guidance his Department has issued to health boards on the factors that should be used to determine the severity of alopecia prior to a decision on treatment.
Answer: Healthcare is a devolved matter, and our response outlines information for England only. The Scottish Government is responsible for the activities and decisions of health boards in Scotland.We have made no assessment of the effectiveness of the Severity o...
Answered 2 Jun 2025
Original Parliament recordAlopecia: Medical TreatmentsDepartment of Health and Social CareTabled 19 May 2025AnsweredUIN 53385More
Question: To ask the Secretary of State for Health and Social Care, what discussions he has had with the British Association of Dermatologists on the suitability of Severity of Alopecia Tool scores to determine treatment for alopecia.
Answer: There have been no discussions between the current health ministers in England and the British Association of Dermatologists (BAD) on the suitability of the Severity of Alopecia Tool’s (SALT) scores to determine treatment for alopecia areata.However, we u...
Answered 22 May 2025
Original Parliament recordRitlecitinib: AlopeciaDepartment of Health and Social CareTabled 19 May 2025AnsweredUIN 53384More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of Severity of Alopecia Tool scores to determine the correct treatment of alopecia.
Answer: Healthcare is a devolved matter, and our response outlines information for England only. The Scottish Government is responsible for the activities and decisions of health boards in Scotland.We have made no assessment of the effectiveness of the Severity o...
Answered 2 Jun 2025
Original Parliament recordRitlecitinib: AlopeciaDepartment of Health and Social CareTabled 19 May 2025AnsweredUIN 53383More
Question: To ask the Secretary of State for Health and Social Care, on what age of patient health boards are advised to use Ritlecitinib to treat alopecia.
Answer: The National Institute for Health and Care Excellence (NICE) is the independent body that makes recommendations for the National Health Service in England on the use of new medicines, based on an assessment of clinical and cost effectiveness. The NHS in E...
Answered 23 May 2025
Original Parliament recordRitlecitinib: AlopeciaDepartment of Health and Social CareTabled 19 May 2025AnsweredUIN 53382More
Question: To ask the Secretary of State for Health and Social Care, what guidance his Department has issued to health boards on the prescription of Ritlecitinib to treat alopecia.
Answer: The National Institute for Health and Care Excellence (NICE) is the independent body that makes recommendations for the National Health Service in England on the use of new medicines, based on an assessment of clinical and cost effectiveness. The NHS in E...
Answered 23 May 2025
Original Parliament recordHealth Services: National SecurityDepartment of Health and Social CareTabled 23 Apr 2025AnsweredUIN 47524More
Question: To ask the Secretary of State for Health and Social Care, if he will conduct an audit of health infrastructure classified as critically important to national interests to identify whether they contain Chinese-made components.
Answer: The United Kingdom will not compromise on economic security and will continue to prioritise national security and resilience. We will continue to cooperate with China on trade and investment, recognising that there will also be areas where we need to chal...
Answered 1 May 2025
Original Parliament recordMental Illness: DrugsDepartment of Health and Social CareTabled 21 Feb 2025AnsweredUIN 32356More
Question: To ask the Secretary of State for Health and Social Care, whether the National Institute for Health and Care Research has undertaken research on the potential impact of psychedelic medication on the treatment of severe mental health conditions.
Answer: The Department commissions research through the National Institute for Health and Care Research (NIHR). The NIHR is supporting psilocybin research via the NIHR King’s Clinical Research Facility and the NIHR Maudsley Biomedical Research Centre, where resea...
Answered 5 Mar 2025
Original Parliament recordEndometriosis: ResearchDepartment of Health and Social CareTabled 20 Jan 2025AnsweredUIN 25102More
Question: To ask the Secretary of State for Health and Social Care, how much funding the Government has provided for endometriosis research in each of the last five years; and what proportion of Government-funded medicinal research that accounts for.
Answer: The Department funds research through the National Institute for Health and Care Research (NIHR). The following table shows how much funding the NIHR has awarded for endometriosis research, as well as that spend as a percentage of total urogynaecology res...
Answered 3 Feb 2025
Original Parliament recordDrugs: WomenDepartment of Health and Social CareTabled 20 Jan 2025AnsweredUIN 25101More
Question: To ask the Secretary of State for Health and Social Care, how many medicinal approvals used female physiology as a baseline for testing in each of the last five years.
Answer: The Medicines and Healthcare products Regulatory Agency does not capture this information in a searchable format, however this information would be available in Public Assessment Reports and summaries of product characteristics, where relevant. These docu...
Answered 24 Jan 2025
Original Parliament recordDrugs: GenderDepartment of Health and Social CareTabled 20 Jan 2025AnsweredUIN 25100More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of differences in approved medicines on (a) men and (b) women.
Answer: The Medicines and Healthcare products Regulatory Agency is responsible for approving medicines in the United Kingdom before they are made available to the wider public. This involves a rigorous assessment using data from clinical trials to assess safety a...
Answered 27 Jan 2025
Original Parliament recordDrugs: GenderDepartment of Health and Social CareTabled 20 Jan 2025AnsweredUIN 25099More
Question: To ask the Secretary of State for Health and Social Care, what testing requirements are in place in the approval process to identify the different impacts of medicines on men and women.
Answer: As part of the approval process for new drugs, the impact of sex, on men versus women, is assessed on pharmacokinetics, or exposure, pharmacodynamics, and overall efficacy and safety. The data is assessed in terms of whether any dose adjustments are warra...
Answered 24 Jan 2025
Original Parliament recordHeart Diseases: GenderDepartment of Health and Social CareTabled 20 Jan 2025AnsweredUIN 25098More
Question: To ask the Secretary of State for Health and Social Care, what training is provided to NHS staff to highlight the differences in symptoms of a heart attack between men and women.
Answer: Guidance for National Health Service staff is available through the British Heart Foundation, and specific learning sessions are available to support training, with further information on both available, respectively, at the following two links:https://ww...
Answered 29 Jan 2025
Original Parliament recordHyperemesis GravidarumDepartment of Health and Social CareTabled 30 Aug 2024AnsweredUIN 3591More
Question: To ask the Secretary of State for Health and Social Care, when NHS England last reviewed guidance for hyperemesis gravidarum; and whether that review was shared with (a) the Scottish Government and (b) NHS Scotland.
Answer: We recognise the challenges including the emotional and physical impacts that hyperemesis gravidarum can have on pregnant women and their families. Appropriate and evidence-based guidance is crucial.NHS England regularly reviews all health guidance, inclu...
Answered 9 Sep 2024
Original Parliament recordDentistry: Migrant WorkersDepartment of Health and Social CareTabled 19 Jul 2024AnsweredUIN 858More
Question: To ask the Secretary of State for Health and Social Care how many Ukrainian dentists have completed the Overseas Registration Examination in each of the last three years.
Answer: My Rt hon. Friend, the Secretary of State for Health and Social Care has not had any discussions with the General Dental Council (GDC) regarding the length of time it takes for Ukrainian nationals to take the Overseas Registration Exam (ORE).The Departmen...
Answered 30 Jul 2024
Original Parliament recordDentistry: Migrant WorkersDepartment of Health and Social CareTabled 19 Jul 2024AnsweredUIN 857More
Question: To ask the Secretary of State for Health and Social Care, how many dentists have completed the Dental Overseas Registration Examination in each of the last five years.
Answer: My Rt hon. Friend, the Secretary of State for Health and Social Care has not had any discussions with the General Dental Council (GDC) regarding the length of time it takes for Ukrainian nationals to take the Overseas Registration Exam (ORE).The Departmen...
Answered 30 Jul 2024
Original Parliament recordDentistry: Migrant WorkersDepartment of Health and Social CareTabled 19 Jul 2024AnsweredUIN 856More
Question: To ask the Secretary of State for Health and Social Care, what the average waiting time is for dentists to sit the Overseas Registration Exam.
Answer: My Rt hon. Friend, the Secretary of State for Health and Social Care has not had any discussions with the General Dental Council (GDC) regarding the length of time it takes for Ukrainian nationals to take the Overseas Registration Exam (ORE).The Departmen...
Answered 30 Jul 2024
Original Parliament recordDentistry: Migrant WorkersDepartment of Health and Social CareTabled 19 Jul 2024AnsweredUIN 855More
Question: To ask the Secretary of State for Health and Social Care, what discussions he has had with the General Dental Council on steps to reduce the time take for Ukrainian nationals to take the overseas registration exam to allow them to practice in the UK.
Answer: My Rt hon. Friend, the Secretary of State for Health and Social Care has not had any discussions with the General Dental Council (GDC) regarding the length of time it takes for Ukrainian nationals to take the Overseas Registration Exam (ORE).The Departmen...
Answered 30 Jul 2024
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2024–3 Jul 2025. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →